News

FibroGen Announces Positive Type C Meeting with the FDA for Roxadustat in Patients with Anemia Associated with Lower-Risk Myelodysplastic Syndromes
Detailed price information for Fibrogen Inc CS (FGEN-Q) from The Globe and Mail including charting and trades.